4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000049
Chief Executive Officer acquired 265,820 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Salzmann Peter Chief Executive Officer | 2025-04-01 | Grant or award | +265,820 | 1,214,606 | D | ||
| Derivatives | |||||||
| Salzmann Peter Chief Executive Officer | 2025-04-01 | Grant or award · Stock Option (right to buy) | +374,395 | 374,395 | D | ||
Loading xslF345X05/wk-form4_1743713207.xml…